Clinical trials research in Maryland

Max Kates, M.D. is a leading institution located in Timonium, Maryland, United States, specializing in urologic oncology. Dr. Max Kates, an Associate Professor of Urology and Oncology, heads the Division of Urologic Oncology at the prestigious Brady Urological Institute. With expertise in bladder and prostate cancer, Dr. Kates offers personalized treatment plans utilizing open, endoscopic, and robotic surgical approaches. He is dedicated to open communication with patients, their families, and referring providers to ensure a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic at Johns Hopkins Greenberg Bladder Cancer Institute, Dr. Kates collaborates with a team to deliver cutting-edge precision medicine approaches for bladder cancer patients. His research interests focus on novel treatments for urinary tract cancers, with over 135 journal articles to his credit. Dr. Kates is also the principal investigator on multiple trials, including the groundbreaking EA8212 BRIDGE trial comparing BCG to GemDoce chemotherapy for early stage bladder cancer.

Julie Brahmer is a renowned doctor specializing in health and wellness, located at 300 Mason Lord Drive in Baltimore, Maryland, United States. With a focus on providing exceptional care and personalized treatment plans, Julie Brahmer is dedicated to helping patients achieve optimal health and well-being. Whether you are seeking preventative care, treatment for a specific health condition, or guidance on improving your overall wellness, Julie Brahmer is committed to providing compassionate and comprehensive care to meet your individual needs.

Nilofer Azad, MD is a renowned institution located at 401 North Broadway, Baltimore, Maryland, United States. Dr. Nilofer S. Azad is an associate professor of oncology at Johns Hopkins University School of Medicine, specializing in cancers of the gastrointestinal tract, particularly colorectal cancer, cholangiocarcinoma, and pancreaticobiliary tract cancer. Dr. Azad's research focuses on early phase drug development and developing new drug combinations for patients with advanced cancer. She is a national leader in GI cancer research and has received numerous grants for her work. The institution is currently recommending masks but not requiring them, due to the downward trend in respiratory viruses in Maryland. Patients are advised to anticipate travel delays to appointments due to the recent collapse of the Francis Scott Key Bridge. Dr. Azad is dedicated to improving survival rates for patients through innovative treatment options and clinical trials.

Amol Narang, MD is a healthcare institution located at 401 North Broadway in Baltimore, Maryland, United States. Specializing in radiation oncology and gastrointestinal cancers, Dr. Narang is an Assistant Professor at Johns Hopkins Department of Radiation Oncology & Molecular Sciences. With a focus on pancreatic cancer, colorectal cancer, hepatobiliary malignancies, and gastric cancer, Dr. Narang is dedicated to providing multi-disciplinary care for patients with gastrointestinal malignancies. Additionally, Dr. Narang is actively involved in clinical trial development surrounding the use of radiation therapy for gastrointestinal cancers, as well as health economics research to improve the value and quality of care provided. Patients can expect personalized and innovative treatment options at Amol Narang, MD. Please note that due to recent transportation disruptions in the Baltimore region, appointments may experience delays, and masks are strongly recommended but not required in Maryland.

Dr. Michael A. Carducci, MD is a renowned medical oncologist located at 1650 Orleans Street in Baltimore, Maryland. He specializes in various types of cancer including bladder, kidney, prostate, and testicular cancer. Dr. Carducci is affiliated with Sibley Memorial Hospital and holds prestigious positions at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center. Dr. Carducci is a fellow of the American College of Physicians and the American Society of Clinical Oncology, with extensive experience in clinical trials, pain and palliative care for oncology, urological oncology, urology, and medical oncology. He has received peer-reviewed funding for his research from organizations such as the National Cancer Institute and the Prostate Cancer Foundation.

Matthias Holdhoff, MD is a renowned medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. Dr. Holdhoff specializes in primary brain cancers and central nervous system lymphomas, with a focus on translational research and clinical trials in neuro-oncology. His extensive education includes a medical degree from Freie Universität Berlin and residency training in internal medicine at Johns Hopkins Bayview Medical Center. Dr. Holdhoff completed a fellowship in medical oncology at Johns Hopkins Hospital, with research training at the Ludwig Center for Cancer Genetics and Therapeutics.

Lisa Jacobs, MD is a leading institution in Baltimore, Maryland specializing in breast cancer surgery, breast surgery, general surgery, melanoma, skin cancer, and surgical oncology. Dr. Jacobs is the Division Chief of the Division of Breast Cancer Surgery and has established the Johns Hopkins Medicine Breast Center at Johns Hopkins Howard County Medical Center in Columbia. Patients can be seen at both The Johns Hopkins Hospital and Johns Hopkins Howard County Medical Center. Dr. Jacobs leads a team of 9 expert surgeons across various medical centers in the region. She is dedicated to providing excellent, comprehensive, and patient-centered breast cancer care through collaboration with various medical specialties. Dr. Jacobs also has a clinical interest in the treatment of early stage melanoma and has launched research programs in lymphedema and oncoplastic surgery. The institution is committed to improving the awareness and care of breast cancer and melanoma patients through educational programs and clinical research trials. Masks are strongly recommended but not required in Maryland clinical locations. Due to the recent collapse of the Francis Scott Key Bridge, patients are advised to anticipate delays when traveling to appointments.

David A. Riseberg, M.D. is a renowned institution located at 227 Saint Paul Place in Baltimore, Maryland, United States. Specializing in medical oncology and hematology, Dr. Riseberg is the Chief of Medical Oncology and Hematology at Mercy Medical Center. Board Certified in Medical Oncology and Hematology, Dr. Riseberg is highly skilled in treating various types of cancers and blood disorders, including breast cancer, colon and rectal cancer, gynecologic cancers, lung cancer, leukemia, and lymphoma. As the Chair of The Cancer Committee at Mercy Medical Center, Dr. Riseberg collaborates with other cancer experts to design care paths for complex cancer cases, ensuring the highest standards of care and optimal patient outcomes. With a focus on breast cancer research and treatment, Dr. Riseberg works closely with a team of specialists at The Breast Center at Mercy to provide coordinated and comprehensive treatment plans for patients, including participation in clinical trials.

Jean Hoffman-Censits, MD is a leading genitourinary cancer specialist located at 1650 Orleans Street in Baltimore, Maryland. Dr. Hoffman-Censits is a co-leader of the Women’s Bladder Cancer Program at the Greenberg Bladder Cancer Institute at Johns Hopkins University School of Medicine. She specializes in treating patients with urothelial cancers of the bladder and upper tract. Dr. Hoffman-Censits is dedicated to conducting research on urothelial cancers and has been involved in groundbreaking clinical trials that have led to new treatments for bladder and upper tract urothelial cancers. She is a member of several prestigious medical associations and has published numerous research articles in top medical journals. Patients visiting Dr. Jean Hoffman-Censits can expect compassionate and expert care for their genitourinary cancer needs. The institution strongly recommends masks for all patients, although they are not required. Due to recent bridge collapse in the area, patients are advised to anticipate travel delays when coming for appointments. Dr. Hoffman-Censits and her team are committed to providing the highest quality of care to all their patients, and strive to make each patient's experience as comfortable and effective as possible.

Dung Le, MD is a renowned institution located at 401 North Broadway, Baltimore, Maryland, United States. Specializing in oncology, Dr. Dung Le is a professor at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. She is actively involved in groundbreaking research focusing on novel approaches to patients with gastrointestinal malignancies. Dr. Le has led numerous clinical trials testing immunotherapy in patients with gastrointestinal malignancies, including studies on pancreatic cancer, liver cancer, and other gastrointestinal tumors. Her research has led to significant advancements in the field of oncology. Due to the recent collapse of the Francis Scott Key Bridge, patients are advised to anticipate delays when traveling to appointments at the Baltimore Region. Masks are strongly recommended but not required in Maryland, as per the latest guidelines. Dr. Dung Le's institution provides top-notch medical care and strives to offer the best possible experience for all patients.

Atif Zaheer, MD is a prestigious institution located at 1800 Orleans Street in Baltimore, Maryland, United States. Dr. Atif Zaheer is a highly respected Professor of Radiology and Radiological Science at Johns Hopkins University School of Medicine, as well as the director of the Cross-Sectional Body Imaging Fellowship program. Dr. Zaheer practices at the renowned Johns Hopkins Hospital in Baltimore. With a medical degree from Aga Khan University and extensive training in diagnostic radiology and abdominal imaging, Dr. Zaheer is a leading expert in the field. He is actively involved in research, education, and clinical practice, specializing in cross-sectional imaging of the body using CT, MRI, and ultrasound. Dr. Zaheer is particularly known for his expertise in imaging tumors and inflammatory disorders of the pancreas, making him a prominent figure in pancreatic imaging.

Julie Brahmer, MD is a leading institution located at 401 North Broadway in Baltimore, Maryland, United States. Dr. Julie Brahmer is the Director of the Thoracic Oncology Program at Johns Hopkins and a Professor of Oncology. She specializes in the treatment of lung cancer and mesothelioma, leading clinical trials and research in immunotherapy and drug development for thoracic malignancies. Dr. Brahmer received her medical degree from the University of Nebraska and completed her fellowship at Johns Hopkins. She is actively involved in various oncology committees and organizations, focusing on advancing treatment options for cancer patients. The institution strongly recommends wearing masks and advises patients to anticipate delays due to recent bridge collapse in the Baltimore region. Dr. Brahmer's dedication to patient care and research has made her a respected figure in the field of oncology.

Evan Lipson, MD is a renowned institution specializing in skin cancer and immunotherapy treatment located at 401 North Broadway, Baltimore, Maryland, United States. Dr. Lipson is an internationally recognized specialist in cutaneous oncology and clinical immunotherapy at Johns Hopkins. He leads cutting edge clinical trials for patients with melanoma and other skin cancers, focusing on evaluating novel therapies for high-risk or advanced disease. Dr. Lipson's research has led to significant advancements in the field, including the development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. Due to the recent collapse of the Francis Scott Key Bridge, patients are advised to anticipate delays when traveling to appointments at the Baltimore location. Masks are strongly recommended but not required in Maryland, following a downward trend in respiratory viruses. Dr. Lipson is also an educator in the field of cancer immunotherapy, providing lectures on immune-mediated drug toxicities associated with novel cancer drugs.

Associates in Oncology, located at 9707 Medical Center Drive in Rockville, Maryland, is a leading institution in cancer care and clinical research. As part of Maryland Oncology Hematology, we offer integrated, evidence-based cancer care to patients in the Maryland community. Our team of dedicated physicians, nurses, and staff are committed to guiding you and your family through your treatment options, personalized to meet your individual needs. Our state-of-the-art infusion centers provide a full range of chemotherapy services, laboratory testing, clinical trials, and support services. At Associates in Oncology, we are dedicated to advancing cancer care and achieving the best possible results for our patients.

Regional Cancer Care Associates in Rockville, Maryland, is a leading institution specializing in oncology, hematology, and infusion clinical services. Located at 9715 Medical Center Drive, our dedicated team of doctors and health professionals are committed to providing high-quality cancer diagnosis and treatment in a compassionate and community-based environment. During the COVID-19 crisis, we are here to support our patients and ensure they have access to the care they need. If you have any questions or concerns about oncology, hematology, or infusion services, please call 833-698-1623. We are also offering virtual visits to ensure the safety and well-being of our patients during the pandemic.

John Wallmark, M.D. is a leading healthcare institution located at 9905 Medical Center Drive in Rockville, Maryland, United States. Dr. Wallmark is dedicated to providing exceptional and compassionate care to his patients, with a focus on innovative research and cutting-edge therapies. He has established a renowned research program that offers state-of-the-art treatments, including early drug development trials, right in the local community. Dr. Wallmark is a published author and specializes in treating breast cancer, lymphomas, myeloma, and leukemia. He is an active member of professional societies such as the American Medical Association and the American Society of Clinical Oncology. Dr. Wallmark has also served as a physician advisor and counselor at the Suburban Breast Center Risk Assessment Program.

John Wallmark, M.D. is a leading institution located at 6420 Rockledge Drive in Bethesda, Maryland, United States. Dr. Wallmark is dedicated to providing exceptional and compassionate care to his patients, with a focus on offering cutting-edge therapies and research programs. With a strong emphasis on developing innovative treatment options, Dr. Wallmark and his team have established a top-tier community research program, allowing patients to access early drug development trials outside of traditional academic centers. Dr. Wallmark is a published author with a special interest in treating breast cancer, lymphomas, myeloma, and leukemia. He is an active member of several professional societies, including the American Medical Association and the American Society of Clinical Oncology. In addition, Dr. Wallmark has served as a physician advisor and counselor at the Suburban Breast Center Risk Assessment Program.

Kashif Ali, M.D. is a highly respected medical oncologist and hematologist located at 11886 Healing Way in Silver Spring, Maryland. Dr. Ali has been recognized as a Washingtonian Top Doctor for multiple years, showcasing his dedication to providing exceptional care to his patients. With a background in molecular biology and experience at top cancer centers, Dr. Ali offers personalized and targeted treatments using the latest medical technology. His passion for research and participation in clinical trials demonstrate his commitment to finding a cure for cancer. Patients can expect compassionate care and support services at White Oak Cancer Center.

Frederick Min, M.D. is a leading healthcare institution located at 11886 Healing Way, Suite 701 in Silver Spring, Maryland. Dr. Frederick Min is a highly experienced clinical investigator and drug developer with a background in internal medicine, clinical pharmacology, and oncology. He has led numerous Phase I clinical trials and has been involved in the development of several novel therapies in the US, Europe, and Asia. Dr. Min is dedicated to providing his patients with the most advanced and up-to-date treatments available. He has been recognized for his outstanding contributions to the field of oncology and has received prestigious awards such as the Rises award from Washington Adventist Hospital and being named one of "America's Top Oncologists" by the Consumers' Research Council of America.

Jefferson Moulds, MD is a leading institution located at 11886 Healing Way in Silver Spring, Maryland, United States. As a doctor specializing in oncology, Dr. Moulds and his team at Maryland Oncology Hematology are dedicated to advancing cancer care by providing access to oncology clinical research. Patients can expect integrated, evidence-based cancer care tailored to their individual needs. The state-of-the-art infusion centers offer a full range of chemotherapy services, laboratory testing, clinical trials, and support services to ensure the best possible outcome for each patient. Trust Jefferson Moulds, MD for compassionate and personalized cancer care.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, located at 6420 Rockledge Drive in Bethesda, Maryland, is a leading institution in cancer care and research. With a focus on multidisciplinary care, the center brings together teams of doctors, nurses, pharmacists, social workers, and advanced practice providers to provide incomparable care for patients in the Washington, D.C., region. As part of Johns Hopkins Medicine, the center offers state-of-the-art treatments, including proton therapy at the Johns Hopkins Proton Therapy Center in Washington, D.C. The center also collaborates with Children's National Pediatric Cancer Care to provide dedicated pediatric radiation oncology programs, ensuring children receive the highest level of care while remaining close to their families and community support systems.

Brandi Page, MD is a renowned institution located at 6420 Rockledge Drive in Bethesda, Maryland, United States. This health facility specializes in providing top-notch medical care in the field of radiation oncology, with a focus on treating various types of cancer. Dr. Brandi Page, an assistant professor of radiation oncology and molecular sciences, leads the team at this institution, offering advanced treatments for brain tumors, head and neck cancers, breast cancer, palliative radiotherapy, and metastatic cancer. In addition to providing exceptional patient care, Dr. Page is actively involved in research and education within the field of radiation oncology. She has contributed to numerous publications, articles, and lectures, focusing on topics such as cancer survivorship, clinical trial design, and cognition and cancer research. Dr. Page is a member of several prestigious medical organizations, including the American Society of Radiation Oncology and the American Radium Society.

Carol K Tweed, MD is a renowned institution located at 810 Bestgate Road in Annapolis, Maryland, United States. Dr. Carol Tweed, a distinguished doctor specializing in medical oncology and hematology, is the driving force behind this institution. With a stellar academic background that includes a degree in Biology from Duke University and a medical degree from Washington University in St. Louis, Dr. Tweed is a highly respected expert in the field. Having previously served as an Assistant Professor at the University of Pennsylvania’s Abramson Cancer Center, Dr. Tweed brings a wealth of knowledge and experience to her practice in Annapolis. She is dedicated to providing exceptional care to patients with a wide range of hematologic and oncologic disorders, with a particular focus on breast cancer.

David E. Weng, MD is a renowned doctor located at 810 Bestgate Road in Annapolis, Maryland. Dr. Weng is dedicated to providing compassionate and state-of-the-art patient care, focusing on understanding and meeting the needs of each patient and their family. With a background in leading academic medical centers such as the Cleveland Clinic, National Cancer Institute, and Johns Hopkins Hospital, Dr. Weng brings a wealth of experience to his practice. He has also trained the next generation of oncologists and continues his work in clinical research through Maryland Oncology Hematology. Dr. Weng's expertise in laboratory research, clinical trials, and collaborations with pharmaceutical industries and academic institutions is evident in his numerous publications, patents, and speaking engagements. Visit Dr. Weng for the best care available in oncology and hematology.

The Illinois Medical Oncology Society is a leading institution located at 574E Ritchie Highway in Severna Park, Maryland, United States. This society is dedicated to advancing the field of medical oncology through education, research, and advocacy. With a focus on providing the highest quality care to cancer patients, the Illinois Medical Oncology Society brings together oncologists, researchers, and healthcare professionals to collaborate and stay at the forefront of advancements in cancer treatment. Join us in our mission to improve outcomes for cancer patients and support the oncology community.

Ali Bukhari, M.D. is a renowned medical oncologist and hematologist located at 810 Bestgate Road in Annapolis, Maryland. Dr. Bukhari holds a Bachelor of Science in molecular biology from the University of Connecticut, a Master of Medical Science from Drexel University, and a Master of Science in clinical nutrition from Columbia University. He received his Doctor of Medicine degree from Eastern Virginia Medical School and completed his internal medicine residency at Wright State University/Wright Patterson Air Force Base. Dr. Bukhari then went on to complete a dual fellowship in hematology and medical oncology at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he served as chief fellow. Board certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine, Dr. Bukhari is an active member of the American Society of Clinical Oncology and the American Society of Hematology. He has been recognized for his exceptional achievements in patient enrollment in cancer research trials by the NIH/National Cancer Institute Community Oncology Research Program (NCORP). Dr. Bukhari has been published in prestigious journals such as the Journal of Clinical Oncology and Blood Advances.

Carol Tweed is a renowned doctor specializing in medical oncology and hematology, located at 8926 Woodyard Road in Clinton, Maryland. Dr. Tweed's impressive educational background includes graduating summa cum laude from Duke University with a degree in Biology, and receiving her medical degree from Washington University in St. Louis where she was elected to Alpha Omega Alpha. She completed her Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Pennsylvania, where she later served as an Assistant Professor at the Abramson Cancer Center. Dr. Tweed is a dedicated expert in breast medical oncology, caring for patients with various hematologic and oncologic disorders. She is actively involved in clinical research and has been a principal investigator on numerous clinical trials. In addition to her clinical work, Dr. Tweed is a member of the Editorial Board of the National Cancer Institute PDQ and is a regional speaker on breast cancer and cancer genomics.

Kathan D Mehta, MBBS, MPH is a board-certified hematologist oncologist located at 7501 Surratts Road, Clinton, Maryland, United States. He is directly employed by MedStar Health and specializes in providing personalized care for patients with blood disorders and cancers. Dr. Mehta offers a range of treatment options, including chemotherapy, immunotherapy, and hormonal therapy, and is dedicated to advancing research in complex blood diseases and tumors. He is a member of esteemed medical societies such as the American Society of Clinical Oncology and American Society of Hematology. Patients can expect comprehensive care plans, post-treatment support, and access to cutting-edge clinical trials through MedStar Georgetown Cancer Institute. Dr. Mehta values the uniqueness of each patient and takes the time to understand their individual backgrounds to optimize their overall health and well-being. With a focus on evidence-based care and a multidisciplinary team approach, patients can trust in the expertise and compassion of Dr. Mehta and MedStar Health.

Ali Bukhari, M.D. is a renowned medical oncologist and hematologist located at 509 Idlewild Avenue in Easton, Maryland, United States. Dr. Bukhari holds a Bachelor of Science in molecular biology from the University of Connecticut, a Master of Medical Science from Drexel University, and a Master of Science in clinical nutrition from Columbia University. He obtained his Doctor of Medicine degree from Eastern Virginia Medical School and completed his internal medicine residency at Wright State University/Wright Patterson Air Force Base. Dr. Bukhari also completed a dual fellowship in hematology and medical oncology at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he served as chief fellow. Board certified in hematology, medical oncology, and internal medicine, Dr. Bukhari is an active member of the American Society of Clinical Oncology and the American Society of Hematology. He was awarded the Silver Certificate of Excellence by the NIH/National Cancer Institute Community Oncology Research Program in 2022 for his outstanding patient enrollment in cancer trials. Dr. Bukhari has been published in prestigious journals such as the Journal of Clinical Oncology and Blood Advances.

Patrick Forde is a doctor specializing in the treatment of lung cancer, mesothelioma, and other thoracic cancers. Located at 201 North Broadway in Baltimore, Maryland, United States, Dr. Forde completed his training in internal medicine and oncology in Ireland before joining Johns Hopkins. As the Co-Director of the Division of Upper Aerodigestive Malignancies in the Department of Oncology, he leads the multidisciplinary Thoracic Oncology Clinical Research Program. Dr. Forde's research focuses on immuno-oncology for upper aerodigestive malignancies, leading to the development of several ongoing phase 3 trials. His work has been instrumental in the FDA approval of neoadjuvant chemo-immunotherapy for surgically operable lung cancer. Patients can expect compassionate care from Dr. Forde and his team of oncology specialists. Please note that due to the recent collapse of the Francis Scott Key Bridge, there may be delays when traveling to appointments. Masks are strongly recommended but not required in Maryland clinical locations.